In a controversial 2008 decision, the FDA gave a fast-track approval for the pricey drug for *** cancer treatment based on a single study. Now, after subsequent research proved disappointing, the agency is moving to revoke the approval, angering patients
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/06/29/137493653/avastin-as-breast-cancer-treatment-tests-fdas-ability-to-say-no?ft=1&f=103537970
Posted
Jun 29 2011, 07:00 AM
by
NPR Blogs: Shots - Health Blog